StairMed (阶梯医疗)established in 2021 and located in Shanghai, is a company engaged in the research and development of brain-computer interface technology. The company has a registered capital of 1 million RMB, exceeding 29% of its peers in Shanghai, and completed its Series A funding round in 2022, with a transaction amount in the hundreds of millions of RMB. Abbreviated as StairMed, it is a pioneering innovative enterprise in the field of implantable brain-computer interfaces. StairMed is dedicated to the research and breakthroughs in implantable brain-computer interface technology, with applications in medical scenarios such as human function restoration, disease treatment, and functional enhancement, as well as related scientific research.